Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer
Clinical trial NCT00269152 · COMPLETED
Trial details
- NCT number
- NCT00269152
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2007-11-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.